Abstract
Introduction

50
Variation within the highly polymorphic MHC region is the primary genetic component linked to immune 51 control of HIV-1 (28, 76) . This effect is due almost entirely to specific HLA-I alleles, many of which have 52 been previously linked with rates of HIV disease progression in molecular epidemiology studies (22, 24, 53 <2,000 viral copies/ml plasma and >250 CD4+ T cells/mm 3 were defined to be "viremic controllers". Due 124 to the geographic heterogeneity of the Thames Valley cohort, this cohort was excluded from viral load 125
analyses. Viral load and high resolution HLA typing were available for 1,870 individuals from the 126 remaining cohorts. 127
A phylogenetically-corrected odds ratio 128 To allow us to quantify and compare the strength of selection pressure exerted by a particular HLA allele 129 on a given HIV-1 codon, we adapted standard logistic regression techniques to take into consideration 130 underlying evolutionary relationships between the HIV-1 sequences in the dataset, yielding a statistic we 131 call the "phylogenetically-corrected odds ratio" of escape, which measures the strength of selection 132 exerted by an HLA allele on a given polymorphism. 133
Logistic regression is a model used for predicting the probability of occurrence of a binary event, 134 making it useful for modeling the probability of observing particular viral amino acids as a function 135 various predictors (such as HLA alleles or viral load). For this reason, logistic regression was used in the 136 first population-level immune escape study (60) . The model can be described as follows. Suppose we are 137 interested in the probability of seeing a particular amino acid at a particular position, say 242N in HIV-1 138
Gag. If is the probability of observing 242N, then the odds of observing 242N is / 1
. Logistic 139 regression models the log of the odds ("log-odds") as a linear function of predefined predictors. For 140 example, if we assume the odds of seeing 242N depends on whether an individual expresses HLA alleles 141 X or Y, then ln , where and are taken to be 0/1 binary variables, and , and 142 are scalar parameters whose values are chosen so as to maximize the likelihood of the data. 143
Conveniently, the maximum likelihood parameters have intuitive interpretations: represents the log-144 odds of observing 242N among individuals who express neither nor ; and is the log-odds ratio of 145 242N among individuals who express HLA compared to individuals who do not express (and 146 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from similarly for and ). A positive log-odds ratio ( 0) indicates that 242N is more likely to be observed 147 among individuals expressing the allele than among those not expressing the allele, while a negative log-148 odds ratio ( 0) indicates the opposite. Thus, if a typical escape is T242N mediated by X=B*57:03, 149 then we would expect to see a negative weight when computing the odds of T and a positive weight 150 when computing the odds of N. 151
Although logistic regression is broadly applied in biomedical research, it can yield surprisingly 152 high false positive and false negative rates when applied to viral sequences, which share an evolutionary 153 relationship (11, 21) . This problem can be circumvented in the special case where the transmitted virus 154 sequence is known; however, in the vast majority of cases the transmitted viral sequence is unknown. 155
To get around this issue, we perform maximum-likelihood phylogenetic reconstructions of the HIV-1 156 sequences observed in the dataset (one maximum likelihood tree for gag-pol and another for nef, 157 estimated using PhyML 3.0 (36)) in order to estimate the transmitted viral sequence for each subject. A 158 statistical model can then be made "phylogenetically-corrected" by designing that model to make use of 159 both the estimated transmitted and the observed current viral sequences, then averaging over the 160 possible phylogenetic histories, as previously described (19, 21) . 161
To create a phylogenetically-corrected logistic regression test, we therefore first need to define 162 a logistic regression model for cases in which both the transmitted and current viral sequences are 163 known for each individual. To this end we modify the above definition to be ln , 164
where represents a binary variable indicating whether or not the transmitted sequence contained 165 242N. We model as a -1/1 binary variable whereas the HLA variables and are modeled as 0/1 166 binary variables. Thus, if an individual expresses neither nor , then the log-odds of observing 242N 167 will be if the transmitted sequence contained 242N, and if it did not. After picking maximum-168 likelihood values for , and , we can then interpret as the log odds ratio comparing the odds of 169 The distinction between an odds ratio conditioned on the transmitted sequence and a more 172 traditional odds ratio is important. In the traditional case, we model the odds of carriage of a specific 173 polymorphism (regardless of whether it was acquired at transmission or subsequently selected in vivo) 174 in individuals expressing the relevant HLA allele compared to those not expressing it. The magnitude of 175 the traditional odds ratio is therefore influenced by the frequency of the polymorphism in persons 176 expressing the relevant HLA allele, as well as its prevalence in the overall population. Thus a high odds 177 ratio may result either from a high probability of escape in individuals expressing the HLA allele, or a 178 high level of conservation among individuals not expressing the allele. In contrast, when we condition on 179 the transmitting sequence, we effectively model the odds of observing the selection of this mutation in 180 vivo (because both the observed and transmitted variants are included in the model). In the context of 181 HLA-mediated escape, the magnitude of an odds ratio that is conditioned on the transmitted virus can 182 therefore be viewed as a measure of the strength of selection in vivo. 183
In practice, we cannot observe the infecting sequence in large cross sectional cohorts. 184
Therefore, we perform a weighted average over all possible infecting sequences, where the weights are 185 informed by the phylogeny (19 
Multiple hypothesis testing
204
In the present study, we perform thousands of statistical tests. In such scenarios, the standard 205 interpretation of the p-value has relatively little meaning. We therefore primarily report false discovery 206 rates, which addresses multiple hypothesis testing (8) . The false discovery rate (FDR) is a property of a p-207 value ( ) in the context of a specific set of tests, and is defined as the expected proportion of tests for 208 which that are false positive. The false discovery rate can be estimated using 209 / , where is the total number of tests performed, is the number of tests with , and 210 is the (unknown) proportion of all tests that are truly null (74) . A straightforward, robust estimate of 211 is 2 , where avg(p) is the average p-value of all the tests (64) . To ensure monotonicity 212 with respect to p-values, the FDR is reported as a q-value, which is the minimum false discovery rate for 213 all (73) . 214 on November 3, 2016 by guest http://jvi.asm.org/
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The appropriate choice of q-value threshold is context-specific and depends on how the results 215 will be interpreted. In the present study, we typically report all tests with q<0.2 (implying that we expect 216 20% of reported tests to be false positives), but will sometimes report lower q-values when more 217 conservative interpretations are appropriate. 218 Therefore, published epitopes have not necessarily been tested in the context of all possible HLA alleles 225 that could present them, nor have the restricting HLA alleles been defined at the same level of 226 resolution throughout. Indeed, many epitopes have only been restricted to one or two alleles whereas 227 others have been attributed to broad serotypes. In recognition of the fact that alleles with shared similar 228 binding grooves are likely to present similar peptides, we expanded the optimal epitope list to include all 229 HLA subtypes belonging to the published HLA type, supertype, or serotype, as follows. For each optimal 230 epitope, we expanded the list of restricting HLA alleles to include all members of the HLA supertype to 231 which the original restricting allele belonged (71) . For optimal epitopes restricted by HLA alleles defined 232
Definition of expanded optimal epitopes
by their serotype only, we expanded the list to include all HLA alleles belonging to that serotype (37) . 233
For HLA-C alleles, which do not have supertype definitions, we expanded the list to include all HLA 234 subtypes belonging to the HLA type of the published restricting allele. 235
We next sought to identify putative HLA escape mutations for each optimal epitope by 236 identifying polymorphisms at sites within or flanking each epitope that were positively or negatively 237 associated with particular HLA alleles. Specifically, for each observed amino acid at each position within 238 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from 3 amino acids of the optimal epitope boundary, we ran a forward selection procedure to identify all HLA 239 alleles that were independently associated with the amino acid. Only HLA alleles that were expressed by 240 at least three individuals in the present study were analyzed; likewise, only polymorphisms that were 241 observed in at least three individuals, and at most N-3 individuals, were considered. For each round of 242 forward selection, we tested each HLA allele using a likelihood ratio test that compared an alternative 243 phylogenetically-corrected logistic regression model that included the new allele to a null model that 244 included all alleles that had been added in previous iterations. After each iteration, the most significant 245 HLA allele was added to the model. The p-value reported for each HLA allele was that computed when 246 the allele was added to the model. As a post-processing step, we filtered the final output to include only 247 those HLA alleles that are in the expanded list of potential restricting HLA alleles and computed q-values 248 based on the resulting subset. In some cases, one escape association could be ascribed to multiple 249 overlapping optimal epitopes, each of which is putatively restricted by the same HLA allele or HLA alleles 250 in the same supertype (e.g., the overlapping Gag epitopes KIRLRPGGK, RLRPGGKKK, and RLRPGGKKKY 251 are all published as A*03:01 optimal epitopes, while the overlapping B7-restricted epitopes VPLRPMTY 252 and RPMTYKAAL are published as B*35:01 and B*07:02 restricted, respectively). In these cases, 253 overlapping optimal epitopes were grouped by published restricting supertype so that each such 254 polymorphism was only analyzed once. We only tested for differential escape between HLA alleles that 255 restricted the same optimal epitope (as determined by the supertype/serotype expansion described 256 above). 257
IFN-γ ELISPOT assays
258
In vitro HIV-specific CD8+ T-cell responses were determined in a cohort of 1010 subtype-C infected 259 individuals using IFN-γ ELISPOT assays using a set of 410 overlapping 18mer peptides (OLPs) spanning 260 the whole HIV-1 subtype C proteome (2001 consensus sequence). Overlapping peptides were arranged 261 in a matrix system with 11-12 peptides in each pool. Responses to matrix pools were deconvoluted by 262 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from subsequent testing with the individual 18mer peptides within each pool, and the identity of the 263 individual 18mers recognized were thus confirmed, as previously described (44). Each optimal epitope 264 was mapped to the OLP(s) that completely contained the optimal. The CTL targeting frequency of each 265 optimal epitope was defined as the targeting frequency of the OLP containing it (or, in the case where it 266 was contained in two OLPs, the maximum targeting frequency between them). Associations between 267 HLA alleles and OLP responses were assessed using a stepwise Fisher's exact procedure. For each OLP, 268
we identified the most significantly associated HLA allele using Fisher's exact test. We then removed all 269 individuals who expressed that allele, and repeated until all HLA alleles had been added to the model. 270
We then computed false discovery rates for each HLA-allele:OLP pair using the method described in 271 (20) , using a web server provided by the authors (http://research.microsoft.com/en-272 us/um/redmond/projects/MSCompBio/FalseDiscoveryRate/). 273
Results
274
Systematic identification of escape mutations in optimally-defined epitopes 275 This study focuses primarily on differential escape within epitopes presented by similar HLA alleles. To 276 this end, we developed a phylogenetically-corrected logistic regression model, which estimates the 277 relative odds of escape among individuals who express a given HLA allele compared to those who do 278 not. As described in Methods, our model conditions on the transmitted sequence (as estimated from the 279 phylogeny), thereby removing any confounding that may arise from evolutionary relatedness among the 280 HIV sequences (11, 19, 21) . By building on the logistic regression model, our model allows us to estimate 281 the relative odds of escape, as well as to explicitly test for differential escape (difference of odds of 282 escape between two alleles) or escape that is dependent on external factors (interaction effects). 283
We first applied this phylogenetically-corrected model to a large population-based dataset to 284 identify associations between individual HLA alleles and HIV-1 polymorphisms occurring within 3 amino 285 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from acids of all optimal epitopes potentially restricted by those alleles. Potential HLA-optimal epitope 286 restriction was defined by expanding the published list of optimally-defined epitopes (52) to include all 287 HLA alleles in the same supertype family as the published restricting alleles (see Methods). A forward 288 selection algorithm was used to reduce the risk of false positives arising from linkage disequilibrium 289 among HLA alleles (19) . We identified 301 significant (q<0.2, p<0.004) HLA-HIV associations in Gag 290 (n=147), Pol (n=110), and Nef (n=44), covering 90 of 157 (57%) optimal epitopes ( Table S3 ). In what 291 follows, we say that an HLA allele "restricts" an epitope if that allele is in the expanded optimal list and 292
is associated with at least one escape polymorphism. There was an average of 1.9 HLA alleles that 293 restricted each of those 90 optimal epitopes. Thirty-eight epitopes were restricted by more than one 294 HLA allele ( Table 1 ) and 67 epitopes were restricted by an allele other than its published restricting one. 295
Thus, in addition to identifying putative HLA-specific escape mutations, this analysis expands the 296 number of closely related HLA alleles capable of presenting each optimal epitope by using escape 297 mutations as indicators of active immune selection pressure in vivo. 298
Widespread differential escape among HLA alleles restricting the same 299 epitope 300 Examination of HLA-associated polymorphisms in Table 1 gives the impression that different HLA alleles 301 restricting the same epitope will select for the same escape mutation only rarely. However it would be 302 premature to draw this conclusion from the association lists alone without undertaking rigorous 303 statistical tests. For example, the absence of any particular association may be due to lack of statistical 304 power. Furthermore, two apparently identical associations may actually occur at substantially different 305 frequencies among individuals expressing two different HLA alleles despite achieving statistical 306 significance in both cases. We therefore created a statistical test for differential escape based on the 307 phylogenetically-corrected logistic regression that allows us to explicitly test whether the odds of escape 308 mediated by two different HLA alleles are different. 309
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For each HLA-associated polymorphism in Table 1 we tested for differential selection between 310 the reported allele and every other HLA allele that restricted the same epitope. In so doing, we confirm 311 that HLA alleles restricting the same epitope exhibit differential escape in the vast majority of cases. 312
Using the estimation method of Pounds and Cheng (64) , which compares the observed distribution of p-313 values for a large number of statistical tests against the expected distribution of p-values under the null 314 hypothesis, we estimate that roughly 70% of the 499 comparisons represent truly differential selection. 315
Thus, differential selection appears to be the norm among HLA alleles that restrict the same epitope. 316
Indeed, of the 38 epitopes that are restricted by multiple members of the same supertype, 37 (97%) 317 exhibited differential escape in at least one position within or flanking the epitope. The only exception 318 was RT-IL9 (IEELRQHLL), which was restricted by B44 supertype members B*18:01 and B*44:03. Tests 319 for differential escape did not achieve statistical significance despite the observation that the two alleles 320
were associated with different polymorphisms (Table 1) . Overall, a total of 278 instances of differential 321 escape within the same epitope were observed at p<0.05 (q<0.025); these are listed in Table S4 . Figure  322 1 displays the subset of these instances for which p<0.005 (q<0.006). 323
Three broad categories of differential immune escape 324
Differential escape (Table S4) can be classified into three patterns. Firstly, we observe cases where two 325 alleles select for the same escape mutation, but to differing degrees. Secondly, we observe cases where 326 one allele selects for escape whereas the other allele shows no association whatsoever. Finally, we 327 observe cases where one allele is significantly positively associated with a polymorphism, and the other 328 allele is significantly negatively associated with the same polymorphism, a phenomenon termed "push-329 pull" escape (14) . argues against this interpretation in most cases. Similarly, although some of these could represent cases 358 of "push-pull" escape where statistical power was insufficient to detect it, this is also not likely to be the 359 explanation in most cases. Specifically, because odds ratios simply reflect the odds of selection among 360 individuals who express the allele versus individuals who do not, observation of a statistically 361 insignificant negative odds ratio by one allele alongside a significant positive odds ratio by another does 362 not necessarily imply active selection against the polymorphism by the former allele. More likely, these 363 insignificant negative odds ratios indicate a complete lack of selection on the part of the former 364 restricting allele. What can thus be clearly concluded from the data is that at least 184 of 278 (66%) 365 cases of observed differential selection represents instances in which the two HLA alleles drive distinct 366 escape pathways within the epitope, as evidenced by opposing odds ratios. 367
Differential escape among protective B58 supertype alleles 368 We next used this approach to study in detail the escape pathways selected by the clinically important 369 B58 supertype alleles B*57:02, B*57:03 and B*58:01 (note that B*57:01 frequency is negligible in 370 African populations). We systematically compared the odds ratio of escape among the three alleles for 371 every significant association reported in Table S3 hypothesis, we devised a statistical test that utilized a multiplicative interaction term between two 426 alleles. Although several tests had p<0.001, these were not significant after correcting for multiple tests 427 (q>0.9 over 13 545 tests; data not shown). We next hypothesized that individuals who are homozygous 428 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from for a restricting allele will be more likely to escape. Once again, we observed no clear trends in the data 429 (7 associations with 0.2 < q < 0.6, the rest with q>0.9; data not shown)
tests). 435
Risk of escape is independent of cohort 436
One possible cause of differential escape is within-host T-cell receptor diversity, a factor that could also 437 vary by population studied. Such variations could arise due to population-specific genetic characteristics 438 or variations in antigenic exposure arising from region-specific vaccinations or diseases. Although we 439 cannot explore the impact of TCR diversity on escape at the individual level, it is possible to investigate 440 whether population level differences could confound the present analyses. To test this, we recomputed 441 differential escape p-and q-values while conditioning on the cohort for which each individual was 442 recruited. The resulting q-values were nearly identical to the original analysis (R 2 = 0.99, data not 443 shown), indicating that differential escape could not be explained by region specific variations (as 444 approximated by cohort). We next tested if the odds of escape mediated by a specific allele were 445 dependent on either cohort or country of origin (excluding the heterogeneous Thames Valley Cohort). 446
Once again, no significant cohort effects were observed (minimum q=1 for both tests). Taken together, 447 we found no evidence for odds of escape being a function of cohort or country of origin, suggesting that 448 the dominant causal mechanism underlying the differential escape observed in the present study is 449 more closely linked to specific HLA alleles than any unmeasured attributes that would be expected to 450 correlate with ethnicity or region. 451 on November 3, 2016 by guest http://jvi.asm.org/
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Population escape patterns predict the majority of intra-epitopic variation 452 The statistical evaluation of escape across individuals, such as the analyses described here, are 453 inherently biased towards identification of common pathways of escape. Although the large size of our 454 combined cohorts allows us to identify some uncommon escape pathways (over all associations, 455 frequency of escape in individuals with the associated HLA allele ranged from 1.6% to 100%, IQR 11%-456 73%), very rare escapes, or rare escapes to uncommon HLA alleles, will go undetected (the statistical 457 power falls precipitously for HLA alleles occurring in fewer than 1% of the population; data not shown). 458
To investigate the ability of population-based approaches to detect evidence of rare escape, we 459 sought to identify whether optimal epitopes inherently display more sequence variation in individuals 460 expressing the restricting allele compared to those who do not. For each optimal epitope we tested for 461 association between expression of any of the restricting HLA alleles and the presence of at least one 462 non-consensus residue within the epitope, excluding at defined escape sites. This analysis will therefore 463 identify epitopes in which variation commonly or occasionally occurs at any epitope position not 464 identified in our previous analyses. Only 32 of 90 (36%) epitopes exhibited signs of increased general 465 variation among individuals expressing the relevant HLA allele (q<0.2). The majority of these (N=24) 466 were in Pol, for which the present study had the least statistical power due to low sequence coverage 467 (e.g. integrase sequences were only available for 344 individuals). Overall, the median proportion of 468 HLA-matched individuals with a non-consensus residue at ≥1 non-HLA-associated site was 18% 469 compared to 13% in HLA mismatched individuals. To provide context, the median proportion of HLA-470 matched individuals with a non-consensus residue at ≥1 HLA-associated site was 40%. This analysis 471
suggests that the majority of escape mutations within HLA-optimal epitope pairs analyzed in this study is 472 captured by the list of HLA-associated polymorphisms in Table S3 , but also supports the selection of 473 unidentified rare escape pathways in some cases. This conclusion is broadly in line with a previous 474 report on longitudinal acute clade B data, in which 32-58% of observed substitutions (those achieving 475 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from >25% frequency in a given quasispecies, as limited by "bulk" RT-PCR and sequencing protocols (47, 48) ) 476 in the first two years of infection exactly matched predicted HLA-associated polymorphisms identified in 477 a chronically infected clade B cohort (13) . Restricting that analysis to substitutions occurring inside 478 optimally defined, HLA-matched epitopes shows that 80%, 52% and 43% of intra-epitopic substitutions 479 in Nef, Gag and Pol, respectively, are attributable to HLA-associations used in that study ((13) and 480 unpublished data). 481
Taken together, these data suggest that population studies with statistical power comparable to 482 the present study are able to identify the majority of common escape mutations occurring in optimally 483 defined epitopes, as well as some rarer mutations that smaller studies have missed. There is also, 484 however, evidence of intra-epitopic variation that is not captured by the present study and which may 485 confer immune escape. It is unknown to what extent such rare escape pathways play a role in immune 486 evasion. Furthermore, the current study focused exclusively on well-characterized epitopes, which may 487 be more conserved than uncharacterized epitopes and may therefore display less variability in escape 488
patterns. 489
Alleles exhibiting differential escape exhibit discordant associations with viral 490 load 491 The B58 supertype alleles B*57:03 and B*58:02 exhibit opposing correlations with plasma viral load (VL) 492 in clade C infection, with B*57:03 strongly correlated with low VL and B*58:02 strongly correlated with 493 high VL (44, 49). These two alleles restrict completely different epitopes in HIV-1, which may account for 494 these differences. Likewise, the B7 epitopes B*81:01, B*42:01 and B*07:01, which select for differential 495 escape patterns within shared epitopes also exhibit discordant associations with VL (44, 49, 50). We thus 496 hypothesized that similar HLA alleles that select differential escape mutations within the same epitope 497 will commonly exhibit discordant associations with VL. 498
We therefore analyzed a dataset of 1,870 chronically C-clade infected, antiretroviral naïve adult 499
Africans to test for associations between HLA alleles and VL. We first sought to identify which HLA alleles 500 are independently and significantly associated with viral load. To this end, we tested all HLA subtypes 501 using forward selection on a linear regression model, conditioned on the cohorts from which each 502 sample was derived, with log 10 VL as the dependent variable. From the distribution of p-values, we 503 estimate that 20% of the 98 HLA alleles tested are truly associated with VL. Using p<0.05 (q<0.13) as a 504 threshold, we identified 20 HLA alleles that contribute to VL. These alleles were jointly added to a linear 505 regression model to determine their independent contributions to VL ( Figure 3A) . Eight of these alleles 506
were associated with reduced VL ("protective" alleles), while 12 were associated with increased VL 507 ("hazardous" alleles). Of note, 6 of the 12 (50%) hazardous alleles selected for escape in an epitope that 508 was also restricted by at least one protective allele and 5 of those cases were classified as differential 509 escape. 510
Simply identifying HLA alleles independently and significantly associated with VL, however, may 511 be overly conservative. Indeed, two alleles that are not individually significantly associated with VL may 512 have significantly discordant associations with VL if, for example, one allele tends to increase while the 513 other tends to decrease VL. We therefore tested for discordant associations between HLA alleles and VL 514 using the linear analogue of the differential selection model (with no correction for phylogeny, as none 515 was needed). To reduce the possibility of confounding due to linkage disequilibrium, we conditioned all 516 tests on the set of HLA alleles individually associated with VL (those in Figure 3A ). Using this model, an 517 estimated 35% of HLA alleles that restrict the same epitope but select for differential escape also have 518 discordant associations with VL. Twenty-seven pairs were significant at q<0.2 (p<0.1; Table S5), and 11 519 were significant at q<0.05 (p<0.011; Figure 3B ). These differences were dominated by members of the 520 A1, A3, B7 and B58 supertypes. Thus, these results indicate that similar HLA alleles that restrict the same 521 epitope, yet select for different escape pathways, often have discordant associations with viral load. 522 on November 3, 2016 by guest http://jvi.asm.org/
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We next looked at whether various features of escape or targeting differentiated protective HLA 523 alleles from hazardous ones. For this analysis, we built a single linear model that included all HLA alleles 524 from Figure 3A and B except the HLA-C alleles (for which there are few published epitopes), and 525 interpreted the β estimates as the relative contribution of each allele to VL. We then correlated various 526 HLA allele features against these β estimates. Over all 32 HLA alleles there was a strong correlation 527 between the total number of Gag-OLPs associated with the allele and VL contribution (Spearman ρ=-528 0.50, p=0.006), and a weak association between Pol/Nef-OLPs with VL contribution (ρ=-0.41, p=0.03; 529 Figure 4A ). An even stronger correlation was observed between VL contribution and the total number of 530 optimal epitopes with associated escape polymorphisms in both Gag (ρ=-0.72, p=1.7x10 -5 ) and Pol/Nef 531 (ρ=-0.46, p=0.01; Figure 4B) . Furthermore, the total number of escape polymorphisms observed per 532 epitope across Gag/Pol/Nef was strongly correlated with VL contribution in HLA-B alleles (ρ=-0.77, 533 p=3.5x10 -4 ) but not HLA-A alleles (ρ=-0.04, p=0.9; Figure 4C ), and the overall strength of escape 534 associations was more statistically significant in protective alleles (median q=0.001) than in hazardous 535 alleles (median q=0.03; p=0.003, Mann-Whitney test). Of note, there was no difference in the entropy of 536 epitopes restricted by protective vs. hazardous alleles (p=0.38), nor was there any difference in the 537 entropy at the sites of associated escape (p=0.96). Taken together, these results indicate that the 538 presence of HLA-associated polymorphisms at the population level is a marker of effective epitope 539 targeting, especially among CTL that target HLA-B restricted Gag epitopes. 540 Although escape at the population level may indicate that CTL restricted by an HLA allele can be 541 quite effective, escape in an individual may indicate that the epitope can no longer be effectively 542 targeted in that individual. We therefore tested each HLA-associated polymorphism for an association 543 with viremic controller status (VL<2000 copies/ml and CD4 counts >250), using the interaction model 544 described in Methods. Although only four associations were significant at q<0.2 (data not shown), the 545 overall trends were striking. Consistent with observations of reduced escape in clade B infected elite 546 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from controllers (59), 201 of 300 (67%) tests indicated that viremic controllers were less likely to have 547 selected for a given escape than were non-controllers (p=3.9x10 -9 ); 13 of 15 (88%; p=0.0002) 548 associations with q<0.5 indicated that viremic controllers were less likely to have selected for escape. 549
This effect was largely driven by conserved regions: when a site is relatively conserved, viremic 550 controllers were much less likely to escape than were non-controllers, whereas the odds of escape was 551 similar between the two groups in non-conserved regions (Spearman correlation between entropy and 552 relative log-odds of escape between controllers and progressors was ρ=-0.31, p=0.0002; data not 553 shown). Of note, protective alleles were not more likely than other alleles to exhibit differential odds of 554 escape between viremic controllers and progressors (p=0.77, Fisher's exact test). 555
Discussion
556
The present study represents the first large scale, systematic analysis of differential immune escape in 557 HIV-1. Starting with optimally defined, published epitopes (52), we identified all related HLA alleles 558 driving immune escape mutations in Gag (p17+p24), Pol and Nef. This list included 38 epitopes 559 restricted by more than one HLA allele, which underscores the promiscuous nature of many CTL 560 epitopes (17, 30, 54, 66, 77) . Remarkably, distinct mutational patterns and risk of escape were observed 561 in 37 of 38 of those epitopes, indicating that differential escape within promiscuous epitopes is typical. 562
These numbers are almost certainly underestimates resulting from restricting the study to known, 563 optimally defined epitopes. 564
There are several reasons why the odds of selecting a given escape polymorphism may differ 565 based on the specific HLA allele restricting the epitope. One possibility is that epitope targeting 566 frequency differs based on the restricting HLA allele. If this were the case, then differential selection 567 pressure would tend to be simply a matter of degree, with the more frequently-targeted HLA restricted-568 epitopes exhibiting higher odds of escape. Although we do observe a small number of distinct escape 569 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from patterns that that can be explained in this straightforward way (e.g., B*57:03, B*57:02 and B*58:01 all 570 select for T242N escape in Gag-TW10, but to differing degrees), the vast majority cannot. Furthermore, 571 in the relatively uncommon cases where two alleles select for the same amino acid polymorphism, no 572 correlation between odds of escape and odds of OLP targeting in chronic infection was observed 573
(although the abrogation of CTL responses following escape in vivo must be acknowledged as a potential 574 limitation of this analysis). Instead, between 66% and 97% of observed cases of differential escape 575 reflect instances where two alleles select for different polymorphisms at the same site or at different 576 sites within the epitope. Taken together, our observations indicate that differential immune selection by 577 closely-related alleles is a widespread phenomenon, and one that typically manifests itself via distinct 578 escape pathways selected by the restricting HLA alleles, rather than common escape patterns that differ 579 in their relative risk of occurrence. This observation is in line with previous studies, which have reported 580 variations in functional avidity, TCR usage, and selection pressure, even in the absence of differential 581 targeting frequency, for several B7-and B58-restricted epitopes (50, 53, 82) . 582
Differential selection and epitope targeting between related HLA alleles suggests that such 583 alleles will have discordant associations with viral load: indeed, this turns out to be true in 584 approximately 35% of cases in which HLA alleles exhibit distinct escape patterns within the same 585 restricted epitope. As such, our results complement previously-described discordant associations with 586 VL among alleles of the B58 supertype (2, 42, 44, 49) , at least some of which appear to be due to the 587 specific epitopes restricted by each allele (25) . Differential escape mutations within A2- (40) 
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Historically, the relationship between immune escape and disease progression has been difficult 594 to elucidate. The complexities of these relationships are illustrated by case studies describing loss of 595 viral control following escape within the immunodominant B*27-restricted Gag-KK10 epitope (27, 35, 596 43) , followed by a dramatic broadening of the CTL response (27) (though breadth of targeting appears to 597 wane as many individuals progress to AIDS (38) ). Thus, in these instances, KK10 escape appears to be a 598 direct cause of viral breakthrough, whereas any escape in epitopes targeted by the subsequent 599 broadened response would occur only after the VL increase. The complexities are compounded by the 600 observation that escape is typically a marker of an (at least previously) effective in vivo CTL response 601 (40) . Indeed, expression of HLA class I alleles associated with a large number of population-level Gag 602 escape associations (16, 31, 65) , a large number of reverting associations (56) , and/or a large number of 603 associations in conserved regions (79) , is predictive of relative viral control. Although escape inherently 604 implies a net improvement of in vivo viral fitness, a number of escape polymorphisms have been linked 605 to decreased in vitro (12, 23, 53, 62, 68, 78) , and in vivo (31, 56) fitness in the absence of CTL pressure, 606
suggesting an incomplete recovery of viral replicative capacity upon escape. Epidemiologically, the 607 presence of costly escape positions could thus be a marker for immune control, as they identify cases of 608 partial immune-mediated attenuation of HIV-1 (58, 65) . Over all associations in the present study, 609 escape was strongly linked to higher VL, an effect that was primarily driven by escape in conserved 610 regions. However, HLA alleles that were associated with many escape polymorphisms, especially in Gag, 611
were themselves associated with low viral load, a correlation that was much stronger than that 612 observed with OLP-measured targeting of Gag. Taken together, these data suggest that, although the 613 presence of population-level escape associations is a marker of the capacity of CTL restricted by that 614 allele to effectively target the virus, loss of viral control is closely linked to actual immune escape in 615 individuals, as was suggested in a chronically infected clade B cohort (16) and in elite controllers (59) . 616
Thus, the study of immune escape in general, and differential escape in particular, may shed light on 617 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from which epitopes are most effective to target in vivo. From a vaccine design perspective, it is equally 618 important to determine if it is possible to block escape from occurring, either through a polyvalent 619 vaccine that primes the immune system to recognize escape variants (29) , or by constraining escape 620 pathways by blocking compensatory mutations through the targeting of other epitopes (80) . The 621 prospects of the latter approach may appear dim given that we found no instances in which the odds of 622 escape were reduced in the context of the co-expression of another HLA allele; however, the present 623 study was underpowered to identify such associations due to the large number (>13 000) of required 624 statistical tests and the low frequency of any given pair of HLA alleles. Some of these associations may 625 represent true interactions and the analytical tool developed here may prove useful for future studies 626 that consider a more restricted set of hypotheses. 627
One key assumption of the present study is that similar HLA alleles that restrict an epitope in a 628
given region are likely to restrict the same optimal epitope. Violations of this assumption could lead to 629 spurious identification of differential escape. Although this assumption remains largely untested, there 630 are several lines of evidence supporting its validity in the majority of cases. First, HLA supertype 631 definitions derive from shared binding profiles and epitope repertoires (17, 30, 71, 72, 77) . The 632 observation that supertypes tend to restrict the same epitopes has been demonstrated in a number of 633 studies (3, 10, 32, 46, 50, 66, 77) and detailed studies of B7-(50) and B58-(46) supertypes consistently 634 yielded identical optimal epitope definitions when multiple alleles were associated with the same OLP. 635
Furthermore, many of the optimal epitopes used in the present study were previously tested in a cohort 636 of 103 HIV-infected individuals (30) . In addition to observing widespread promiscuity, titration 637 experiments using truncated and extended peptides demonstrated that the same optimal epitope was 638 presented in the majority of cases, though several exceptions were noted. Moreover the same epitope 639 was frequently optimal for alleles even of different loci, an effect that may be due to HLA-independent 640 mechanisms such as proteasomal processing, epitope transport or trimming (26, 61, 75) , suggesting that 641 on November 3, 2016 by guest http://jvi.asm.org/ Downloaded from our present approach of limiting epitope expansion to supertype members is conservative. Taken 642 together, the identification of an HLA-associated polymorphism within an optimal epitope known to be 643 restricted by a similar HLA allele suggests that the associated HLA restricts the same optimal epitope. 644
Nevertheless, a handful of known counter examples exist in the published optimal list, indicating that 645 some instances of differential escape may be due to related alleles restricting overlapping epitopes. 646 phylogenetically-corrected logistic model was used to derive a p-value that tests the null hypothesis that 699 both alleles select for escape with the same odds ratio. Comparisons with p<0.005 (q<0.006) are 700 reported. The complete list of all comparisons with p<0.05 is available in Table S4 . 701 
